Schering Global Pharma Restructuring To Intensify Focus On Key Regions
This article was originally published in The Pink Sheet Daily
Executive Summary
Organizational changes will include separation of international business units.
You may also be interested in...
Schering-Plough Sets Acquisition Sights On Specialty Products
The company has entered the third – or “turnaround” – phase of its five-point restructuring program.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.